Regulation & law · 10/12/1996Updated: 10/18/2026 · 1 min read
Medirex, Inc. Receives FDA Approval for Tripter-X1 Series Lithotripters
The US Food and Drug Administration (FDA) has approved Medirex, Inc.'s application for premarket approval of its Tripter-X1 Series Extracorporeal Shock Wave Lithotripters, a medical device used to treat kidney stones.
Original source language: Federal Register — All DocumentsOpen original release →